Deepa Sampath

Deepa Sampath

UNVERIFIED PROFILE

Are you Deepa Sampath?   Register this Author

Register author
Deepa Sampath

Deepa Sampath

Publications by authors named "Deepa Sampath"

Are you Deepa Sampath?   Register this Author

36Publications

591Reads

5Profile Views

Explaining Gene Expression Using Twenty-One MicroRNAs.

J Comput Biol 2019 Dec 2. Epub 2019 Dec 2.

Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cmb.2019.0321DOI Listing
December 2019

HSP90 inhibition depletes DNA repair proteins to sensitize acute myelogenous leukemia to nucleoside analog chemotherapeutics.

Leuk Lymphoma 2019 Sep 18;60(9):2308-2311. Epub 2019 Feb 18.

Division of Hematology, Department of Internal Medicine, The Ohio State University , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1571197DOI Listing
September 2019

Assays on DNA Damage and Repair in CLL.

Methods Mol Biol 2019 ;1881:153-163

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-4939-8876-1_12
Publisher Site
http://dx.doi.org/10.1007/978-1-4939-8876-1_12DOI Listing
June 2019

Role and regulation of microRNAs targeting BTK in acute myelogenous leukemia.

Leuk Lymphoma 2018 06 18;59(6):1461-1465. Epub 2017 Sep 18.

a Department of Internal Medicine, Division of Hematology , The Ohio State University , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1376742DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029688PMC
June 2018

Shielding p53 from destruction.

Authors:
Deepa Sampath

Blood 2018 06;131(25):2740-2741

The Ohio State University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-04-845800DOI Listing
June 2018

Targeting deubiquitinases in CLL.

Authors:
Deepa Sampath

Blood 2017 07;130(2):100-101

THE OHIO STATE UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-06-786236DOI Listing
July 2017

MiRly regulating metabolism.

Authors:
Deepa Sampath

Blood 2012 Sep;120(13):2540-1

MD Anderson Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-08-439596DOI Listing
September 2012

Therapy for older patients with acute myeloblastic leukemia: a problem in search of a solution.

Leuk Lymphoma 2012 Jun;53(6):1013-4

Department of Experimental Therapeutics and Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.676178DOI Listing
June 2012

Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.

Blood 2012 Feb 16;119(5):1162-72. Epub 2011 Nov 16.

Departments of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 1901 East Road, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-05-351510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277352PMC
February 2012

Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures.

J Neurooncol 2011 Nov 20;105(2):241-51. Epub 2011 May 20.

Department of Neuro-Oncology, The Brain Tumor Center, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 431, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0604-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794467PMC
November 2011

Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease.

Clin Cancer Res 2011 Jul 1;17(14):4731-41. Epub 2011 Jun 1.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534342PMC
July 2011

Coding and noncoding: the CLL mix.

Blood 2010 May;115(19):3858-9

M. D. Anderson Cancer Center, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-02-267278DOI Listing
May 2010

miRs: fine-tuning prognosis in CLL.

Blood 2009 May;113(21):5035-6

M D Anderson Cancer Center

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-02-205419DOI Listing
May 2009

Dialing resistance up a Notch.

Leuk Lymphoma 2009 Feb;50(2):158-9

Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802699381DOI Listing
February 2009

ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance.

Cancer Res 2008 Oct;68(19):7947-55

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston Graduate School of Biomedical Sciences, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-0971DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631429PMC
October 2008

miRNAs and their potential for use against cancer and other diseases.

Future Oncol 2007 Oct;3(5):521-37

Ohio State University, Department of Molecular Virology, Immunology & Medical Genetics and Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.3.5.521DOI Listing
October 2007

The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance.

Curr Oncol Rep 2007 Sep;9(5):361-7

Department of Experimental Therapeutics, Unit 71, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11912-007-0048
Web Search
http://dx.doi.org/10.1007/s11912-007-0048-6DOI Listing
September 2007

H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation.

Mol Cancer Ther 2007 Apr 3;6(4):1239-48. Epub 2007 Apr 3.

Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-06-0633DOI Listing
April 2007

Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal.

Blood 2006 Dec 5;108(13):4187-93. Epub 2006 Sep 5.

Department of Experimental Therapeutics Unit 71, The University of Texas M D Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-05-023259DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895455PMC
December 2006

Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial.

Blood 2006 Mar 17;107(6):2517-24. Epub 2005 Nov 17.

Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-08-3351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895741PMC
March 2006

Mechanisms of apoptosis induction by nucleoside analogs.

Oncogene 2003 Dec;22(56):9063-74

The Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207229DOI Listing
December 2003

Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.

Mol Pharmacol 2002 Sep;62(3):680-8

Department of Experimental Therapeutics, the University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/mol.62.3.680DOI Listing
September 2002